Selected research
Market Analysis & Forecast
Global Medical Device Testing and Validation Service Market Analysis and Forecast 2026-2032
Market perspective
The global Medical Device Testing and Validation Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Medical Device Testing and Validation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Medical Device Testing and Validation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Medical Device Testing and Validation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Medical Device Testing and Validation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Medical Device Testing and Validation Service include SGS, TÜV SÜD AG, Intertek Group plc, Element Materials Technology, Bureau Veritas, Pace Analytical Services, Wuxi Apptec, NAMSA and Nelson Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Medical Device Testing and Validation Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Medical Device Testing and Validation Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Device Testing and Validation Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medical Device Testing and Validation Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Device Testing and Validation Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Device Testing and Validation Service revenue, projected growth trends, production technology, application and end-user industry.
Medical Device Testing and Validation Service Segment by Company
SGS
TÜV SÜD AG
Intertek Group plc
Element Materials Technology
Bureau Veritas
Pace Analytical Services
Wuxi Apptec
NAMSA
Nelson Laboratories
Eurofins Scientific
Charles River Laboratories
QuEST Global Services
Medical Device Testing and Validation Service Segment by Type
Biocompatibility Testing Service
Electrical and Mechanical Testing Service
Sterility and Microbiology Testing Service
Others
Medical Device Testing and Validation Service Segment by Application
Regulatory Compliance Testing
Product Safety and Performance Validation
Quality Assurance and Certification
Clinical Evaluation and Trials Support
Packaging and Sterilization Validation
Others
Medical Device Testing and Validation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Testing and Validation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Device Testing and Validation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Testing and Validation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Medical Device Testing and Validation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Medical Device Testing and Validation Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Device Testing and Validation Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biocompatibility Testing Service
- Electrical and Mechanical Testing Service
- Sterility and Microbiology Testing Service
- Others
Applications
- Regulatory Compliance Testing
- Product Safety and Performance Validation
- Quality Assurance and Certification
- Clinical Evaluation and Trials Support
- Packaging and Sterilization Validation
- Others
Companies covered
- SGS
- TÜV SÜD AG
- Intertek Group plc
- Element Materials Technology
- Bureau Veritas
- Pace Analytical Services
- Wuxi Apptec
- NAMSA
- Nelson Laboratories
- Eurofins Scientific
- Charles River Laboratories
- QuEST Global Services
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Medical Device Testing and Validation Service Market by Type
- 1.2.1 Global Medical Device Testing and Validation Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Biocompatibility Testing Service
- 1.2.3 Electrical and Mechanical Testing Service
- 1.2.4 Sterility and Microbiology Testing Service
- 1.2.5 Others
- 1.3 Medical Device Testing and Validation Service Market by Application
- 1.3.1 Global Medical Device Testing and Validation Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Regulatory Compliance Testing
- 1.3.3 Product Safety and Performance Validation
- 1.3.4 Quality Assurance and Certification
- 1.3.5 Clinical Evaluation and Trials Support
- 1.3.6 Packaging and Sterilization Validation
- 1.3.7 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical Device Testing and Validation Service Market Dynamics
- 2.1 Medical Device Testing and Validation Service Industry Trends
- 2.2 Medical Device Testing and Validation Service Industry Drivers
- 2.3 Medical Device Testing and Validation Service Industry Opportunities and Challenges
- 2.4 Medical Device Testing and Validation Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Medical Device Testing and Validation Service Market Perspective (2021-2032)
- 3.2 Global Medical Device Testing and Validation Service Growth Trends by Region
- 3.2.1 Global Medical Device Testing and Validation Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Medical Device Testing and Validation Service Market Size by Region (2021-2026)
- 3.2.3 Global Medical Device Testing and Validation Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Medical Device Testing and Validation Service Revenue by Players
- 4.1.1 Global Medical Device Testing and Validation Service Revenue by Players (2021-2026)
- 4.1.2 Global Medical Device Testing and Validation Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Medical Device Testing and Validation Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Medical Device Testing and Validation Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Medical Device Testing and Validation Service Key Players Headquarters & Area Served
- 4.4 Global Medical Device Testing and Validation Service Players, Product Type & Application
- 4.5 Global Medical Device Testing and Validation Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Medical Device Testing and Validation Service Market CR5 and HHI
- 4.6.3 2025 Medical Device Testing and Validation Service Tier 1, Tier 2, and Tier 3
5 Medical Device Testing and Validation Service Market Size by Type
- 5.1 Global Medical Device Testing and Validation Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Medical Device Testing and Validation Service Revenue by Type (2021-2032)
- 5.3 Global Medical Device Testing and Validation Service Revenue Market Share by Type (2021-2032)
6 Medical Device Testing and Validation Service Market Size by Application
- 6.1 Global Medical Device Testing and Validation Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Medical Device Testing and Validation Service Revenue by Application (2021-2032)
- 6.3 Global Medical Device Testing and Validation Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 SGS
- 7.1.1 SGS Company Information
- 7.1.2 SGS Business Overview
- 7.1.3 SGS Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.1.4 SGS Medical Device Testing and Validation Service Product Portfolio
- 7.1.5 SGS Recent Developments
- 7.2 TÜV SÜD AG
- 7.2.1 TÜV SÜD AG Company Information
- 7.2.2 TÜV SÜD AG Business Overview
- 7.2.3 TÜV SÜD AG Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.2.4 TÜV SÜD AG Medical Device Testing and Validation Service Product Portfolio
- 7.2.5 TÜV SÜD AG Recent Developments
- 7.3 Intertek Group plc
- 7.3.1 Intertek Group plc Company Information
- 7.3.2 Intertek Group plc Business Overview
- 7.3.3 Intertek Group plc Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Intertek Group plc Medical Device Testing and Validation Service Product Portfolio
- 7.3.5 Intertek Group plc Recent Developments
- 7.4 Element Materials Technology
- 7.4.1 Element Materials Technology Company Information
- 7.4.2 Element Materials Technology Business Overview
- 7.4.3 Element Materials Technology Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Element Materials Technology Medical Device Testing and Validation Service Product Portfolio
- 7.4.5 Element Materials Technology Recent Developments
- 7.5 Bureau Veritas
- 7.5.1 Bureau Veritas Company Information
- 7.5.2 Bureau Veritas Business Overview
- 7.5.3 Bureau Veritas Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Bureau Veritas Medical Device Testing and Validation Service Product Portfolio
- 7.5.5 Bureau Veritas Recent Developments
- 7.6 Pace Analytical Services
- 7.6.1 Pace Analytical Services Company Information
- 7.6.2 Pace Analytical Services Business Overview
- 7.6.3 Pace Analytical Services Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Pace Analytical Services Medical Device Testing and Validation Service Product Portfolio
- 7.6.5 Pace Analytical Services Recent Developments
- 7.7 Wuxi Apptec
- 7.7.1 Wuxi Apptec Company Information
- 7.7.2 Wuxi Apptec Business Overview
- 7.7.3 Wuxi Apptec Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Wuxi Apptec Medical Device Testing and Validation Service Product Portfolio
- 7.7.5 Wuxi Apptec Recent Developments
- 7.8 NAMSA
- 7.8.1 NAMSA Company Information
- 7.8.2 NAMSA Business Overview
- 7.8.3 NAMSA Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.8.4 NAMSA Medical Device Testing and Validation Service Product Portfolio
- 7.8.5 NAMSA Recent Developments
- 7.9 Nelson Laboratories
- 7.9.1 Nelson Laboratories Company Information
- 7.9.2 Nelson Laboratories Business Overview
- 7.9.3 Nelson Laboratories Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Nelson Laboratories Medical Device Testing and Validation Service Product Portfolio
- 7.9.5 Nelson Laboratories Recent Developments
- 7.10 Eurofins Scientific
- 7.10.1 Eurofins Scientific Company Information
- 7.10.2 Eurofins Scientific Business Overview
- 7.10.3 Eurofins Scientific Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.10.4 Eurofins Scientific Medical Device Testing and Validation Service Product Portfolio
- 7.10.5 Eurofins Scientific Recent Developments
- 7.11 Charles River Laboratories
- 7.11.1 Charles River Laboratories Company Information
- 7.11.2 Charles River Laboratories Business Overview
- 7.11.3 Charles River Laboratories Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Charles River Laboratories Medical Device Testing and Validation Service Product Portfolio
- 7.11.5 Charles River Laboratories Recent Developments
- 7.12 QuEST Global Services
- 7.12.1 QuEST Global Services Company Information
- 7.12.2 QuEST Global Services Business Overview
- 7.12.3 QuEST Global Services Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 7.12.4 QuEST Global Services Medical Device Testing and Validation Service Product Portfolio
- 7.12.5 QuEST Global Services Recent Developments
8 North America
- 8.1 North America Medical Device Testing and Validation Service Revenue (2021-2032)
- 8.2 North America Medical Device Testing and Validation Service Revenue by Type (2021-2032)
- 8.2.1 North America Medical Device Testing and Validation Service Revenue by Type (2021-2026)
- 8.2.2 North America Medical Device Testing and Validation Service Revenue by Type (2027-2032)
- 8.3 North America Medical Device Testing and Validation Service Revenue Share by Type (2021-2032)
- 8.4 North America Medical Device Testing and Validation Service Revenue by Application (2021-2032)
- 8.4.1 North America Medical Device Testing and Validation Service Revenue by Application (2021-2026)
- 8.4.2 North America Medical Device Testing and Validation Service Revenue by Application (2027-2032)
- 8.5 North America Medical Device Testing and Validation Service Revenue Share by Application (2021-2032)
- 8.6 North America Medical Device Testing and Validation Service Revenue by Country
- 8.6.1 North America Medical Device Testing and Validation Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Medical Device Testing and Validation Service Revenue by Country (2021-2026)
- 8.6.3 North America Medical Device Testing and Validation Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Medical Device Testing and Validation Service Revenue (2021-2032)
- 9.2 Europe Medical Device Testing and Validation Service Revenue by Type (2021-2032)
- 9.2.1 Europe Medical Device Testing and Validation Service Revenue by Type (2021-2026)
- 9.2.2 Europe Medical Device Testing and Validation Service Revenue by Type (2027-2032)
- 9.3 Europe Medical Device Testing and Validation Service Revenue Share by Type (2021-2032)
- 9.4 Europe Medical Device Testing and Validation Service Revenue by Application (2021-2032)
- 9.4.1 Europe Medical Device Testing and Validation Service Revenue by Application (2021-2026)
- 9.4.2 Europe Medical Device Testing and Validation Service Revenue by Application (2027-2032)
- 9.5 Europe Medical Device Testing and Validation Service Revenue Share by Application (2021-2032)
- 9.6 Europe Medical Device Testing and Validation Service Revenue by Country
- 9.6.1 Europe Medical Device Testing and Validation Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Medical Device Testing and Validation Service Revenue by Country (2021-2026)
- 9.6.3 Europe Medical Device Testing and Validation Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Medical Device Testing and Validation Service Revenue (2021-2032)
- 10.2 China Medical Device Testing and Validation Service Revenue by Type (2021-2032)
- 10.2.1 China Medical Device Testing and Validation Service Revenue by Type (2021-2026)
- 10.2.2 China Medical Device Testing and Validation Service Revenue by Type (2027-2032)
- 10.3 China Medical Device Testing and Validation Service Revenue Share by Type (2021-2032)
- 10.4 China Medical Device Testing and Validation Service Revenue by Application (2021-2032)
- 10.4.1 China Medical Device Testing and Validation Service Revenue by Application (2021-2026)
- 10.4.2 China Medical Device Testing and Validation Service Revenue by Application (2027-2032)
- 10.5 China Medical Device Testing and Validation Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Medical Device Testing and Validation Service Revenue (2021-2032)
- 11.2 Asia Medical Device Testing and Validation Service Revenue by Type (2021-2032)
- 11.2.1 Asia Medical Device Testing and Validation Service Revenue by Type (2021-2026)
- 11.2.2 Asia Medical Device Testing and Validation Service Revenue by Type (2027-2032)
- 11.3 Asia Medical Device Testing and Validation Service Revenue Share by Type (2021-2032)
- 11.4 Asia Medical Device Testing and Validation Service Revenue by Application (2021-2032)
- 11.4.1 Asia Medical Device Testing and Validation Service Revenue by Application (2021-2026)
- 11.4.2 Asia Medical Device Testing and Validation Service Revenue by Application (2027-2032)
- 11.5 Asia Medical Device Testing and Validation Service Revenue Share by Application (2021-2032)
- 11.6 Asia Medical Device Testing and Validation Service Revenue by Country
- 11.6.1 Asia Medical Device Testing and Validation Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Medical Device Testing and Validation Service Revenue by Country (2021-2026)
- 11.6.3 Asia Medical Device Testing and Validation Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Medical Device Testing and Validation Service Revenue (2021-2032)
- 12.2 SAMEA Medical Device Testing and Validation Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Medical Device Testing and Validation Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Medical Device Testing and Validation Service Revenue by Type (2027-2032)
- 12.3 SAMEA Medical Device Testing and Validation Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Medical Device Testing and Validation Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Medical Device Testing and Validation Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Medical Device Testing and Validation Service Revenue by Application (2027-2032)
- 12.5 SAMEA Medical Device Testing and Validation Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Medical Device Testing and Validation Service Revenue by Country
- 12.6.1 SAMEA Medical Device Testing and Validation Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Medical Device Testing and Validation Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Medical Device Testing and Validation Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst